Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Prestige Consumer Healthcare Inc.    PBH

PRESTIGE CONSUMER HEALTHCARE INC.

(PBH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/23/2020 11/24/2020 11/25/2020 11/27/2020 11/30/2020 Date
35.86(c) 36.84(c) 36.37(c) 36.67(c) 35.57(c) Last
404 465 258 683 215 393 126 392 479 507 Volume
-0.75% +2.73% -1.28% +0.82% -3.00% Change
More quotes
Financials (USD)
Sales 2021 927 M - -
Net income 2021 164 M - -
Net Debt 2021 - - -
P/E ratio 2021 11,0x
Yield 2021 -
Sales 2022 942 M - -
Net income 2022 168 M - -
Net Debt 2022 - - -
P/E ratio 2022 10,7x
Yield 2022 -
Capitalization 1 782 M 1 782 M -
Capi. / Sales 2021 1,92x
Capi. / Sales 2022 1,89x
Nbr of Employees 520
Free-Float 92,1%
More Financials
Company
Prestige Consumer Healthcare Inc., formerly Prestige Brands Holdings, Inc. is engaged in the marketing, sales and distribution of over-the-counter healthcare products. The Company operates through two segments: North American Over-the-Counter (OTC) Healthcare, and International Over-the-Counter Healthcare. Its portfolio of OTC healthcare products includes core brands, such as DenTek specialty oral care products,... 
More about the company
Notations Surperformance© of Prestige Consumer Healthcare Inc.
Trading Rating : Investor Rating :
More Ratings
All news about PRESTIGE CONSUMER HEALTHCARE INC.
11/05PRESTIGE BRANDS : Fiscal 2Q Earnings Snapshot
AQ
11/05PRESTIGE CONSUMER HEALTHCARE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL..
AQ
11/05PRESTIGE CONSUMER HEALTHCARE INC. : Results of Operations and Financial Conditio..
AQ
11/05PRESTIGE CONSUMER HEALTHCARE : Reports Fiscal 2021 Second Quarter Results
AQ
11/05Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Second Quarter Results
GL
10/07PRESTIGE CONSUMER HEALTHCARE : to Release Fiscal 2021 Second Quarter Earnings Re..
AQ
10/07Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Second Quarter Earni..
GL
08/06PRESTIGE BRANDS : Fiscal 1Q Earnings Snapshot
AQ
08/06PRESTIGE CONSUMER HEALTHCARE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL..
AQ
08/06PRESTIGE CONSUMER HEALTHCARE INC. : Results of Operations and Financial Conditio..
AQ
08/06Prestige Consumer Healthcare Inc. Reports Fiscal 2021 First Quarter Results
GL
07/13Prestige Consumer Healthcare Inc. to Release Fiscal 2021 First Quarter Earnin..
GL
06/30SPRUCE POINT CAPITAL MANAGEMENT RELE : Pbh)
PR
05/08PRESTIGE CONSUMER HEALTHCARE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL..
AQ
05/07PRESTIGE BRANDS : Fiscal 4Q Earnings Snapshot
AQ
More news
News in other languages on PRESTIGE CONSUMER HEALTHCARE INC.
03/26PRESTIGE CONSUMER : gagne +10%, boosté par un broker
03/26PRESTIGE CONSUMER HEALTHCARE : Jefferies passe à l'achat
2016PRESTIGE BRANDS HOLDINGS, INC. : publication des résultats annuels
2016PRESTIGE BRANDS HOLDINGS, INC. : Veröffentlichung des Jahresergebnisses
2013PRESTIGE BRANDS HOLDINGS, INC. : publication des résultats trimestriels
More news
Chart PRESTIGE CONSUMER HEALTHCARE INC.
Duration : Period :
Prestige Consumer Healthcare Inc. Technical Analysis Chart | PBH | US74112D1019 | MarketScreener
Technical analysis trends PRESTIGE CONSUMER HEALTHCARE INC.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 42,75 $
Last Close Price 35,57 $
Spread / Highest target 34,9%
Spread / Average Target 20,2%
Spread / Lowest Target 4,02%
EPS Revisions
Managers
NameTitle
Ronald M. Lombardi Chairman, President & Chief Executive Officer
Jeff Zerillo Senior Vice President-Operations
Christine Sacco Chief Financial Officer
John E. Byom Independent Director
Gary E. Costley Lead Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
PRESTIGE CONSUMER HEALTHCARE INC.-12.17%1 782
JOHNSON & JOHNSON-0.82%380 876
ROCHE HOLDING AG-4.76%282 467
PFIZER, INC.3.21%212 942
NOVARTIS AG-10.48%206 479
MERCK & CO., INC.-11.61%203 389